SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-144344
Filing Date
2022-05-09
Accepted
2022-05-09 08:06:29
Documents
2
Period of Report
2022-05-09

Document Format Files

Seq Description Document Type Size
1 6-K d272240d6k.htm 6-K 44594
2 EX-99.1 d272240dex991.htm EX-99.1 43610
  Complete submission text file 0001193125-22-144344.txt   89227
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 22903321
SIC: 2834 Pharmaceutical Preparations